Thus, increased hepatic expression of IL-17A, IL-17F and IL-17RA suggested that IL-17 axis might play a role in regulation of MCDD-driven NAFLD pathogenesis. This evidence concerns the gene IL17RA and metabolic dysfunction-associated steatotic liver disease.